Other
2027
Amgen 2027 remained flat by 0.0% to $3.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $3.70B to $3.60B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
How to read this metric
Lower projected expenses indicate a reduction in the drag on future net income as assets become fully amortized.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2027. These assets ty...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a31c97Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.50B | $2.50B | $2.50B | $2.50B | $2.50B | $2.70B | $2.70B | $2.70B | $4.50B | $4.50B | $4.50B | $3.70B | $3.70B | $3.60B | $3.60B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +8.0% | +0.0% | +0.0% | +66.7% | +0.0% | +0.0% | -17.8% | +0.0% | -2.7% | +0.0% |
| YoY Change | — | — | — | +0.0% | +0.0% | +8.0% | +8.0% | +8.0% | +66.7% | +66.7% | +66.7% | -17.8% | -17.8% | -20.0% | -2.7% |
Range$2.50B – $4.50B
CAGR+11.0%
Avg YoY Growth+13.8%
Median YoY Growth+4.0%
2027 at Other Companies
Frequently Asked Questions
- What is Amgen's 2027?
- Amgen (AMGN) reported 2027 of $3.60B in Q1 2026.
- How has Amgen's 2027 changed year-over-year?
- Amgen's 2027 decreased by 2.7% year-over-year, from $3.70B to $3.60B.
- What does 2027 mean?
- The expected non-cash expense for acquired intangible assets in the year 2027.